News

Patients with EGFR or ALK genomic tumor aberrations should have disease progression on FDA-approved therapy for these aberrations prior to receiving KEYTRUDA. Under FDA’s accelerated approval regulations, this

The SOLUTION clinical study is designed to evaluate the efficacy and safety of Sollpura, a microbial derived, biotech pancreatic enzyme replacement therapy (PERT), compared to an approved, porcine-derived,

It aims to lower the risks of disease progression and hospitalization for worsening PAH, and enhance exercise ability. The approval followed a study in which the Letairis/tadalafil combination

Ace-ER is designed for the replacement of the deficient sialic acid substrate in patients with GNE Myopathy. A defect in the biosynthetic pathway for sialic acid, with onset

Etanercept is a tumor necrosis factor alpha (TNF-alpha) inhibitor used to treat a range of autoimmune diseases including rheumatoid arthritis and psoriasis. Sandoz head of global biopharmaceutical &

Moxatag is indicated to treat tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adult and pediatric patients of 12 years or more. Vernalis paid an undisclosed up-front cash

This milestone demonstrates Theralase’s ability to consistently and reliably manufacture its lead light activated drug in the same purity and yield as the original GMP batch. Consistency in

Swereco markets OTC products mainly to pharmacies or directly to health care providers. Net sales in 2014 were 150 MSEK. There are several well-established brands in the product

The move forms part of the company’s "Fit for 2018" strategic transformation and growth program, which includes the focus on innovative, technology-driven businesses as well as the modernization